Skip to main content

TDE-HF-302 Open-label extension study of oral Treprostinil in subjects with Pulmonary Hypertension associated wiht Heart Failure with Preserved Ejection Fraction- A long-term follow-up to TDE-HF-301

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Pulmonary, Allergy, and Critical Care Medicine

Awarded By

United Therapeutics Corporation

Start Date

November 7, 2017

End Date

November 14, 2020
 

Administered By

Medicine, Pulmonary, Allergy, and Critical Care Medicine

Awarded By

United Therapeutics Corporation

Start Date

November 7, 2017

End Date

November 14, 2020